Concepedia

Marie‐Sara Agier

MA

Statistics

Publications

2

Citations

174

H-Index

2

Active since

2019

Affiliations

Université de Tours(Current)

Centre Hospitalier Universitaire de Grenoble

Inserm

Centre Hospitalier Universitaire de Tours

Marie‐Sara Agier is an author at Université de Tours specializing in hematology, placebo-controlled efficacy assessment, and pharmacotherapy.

Publications per year

2019–2023

2

Publications

2

Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial

Julie Mankikian, Agnès Caille, Martine Reynaud‐Gaubert et al. · European Respiratory Journal · 2023 · 121 citations · Full text

, , +13

Rituximab-induced serum sickness is more frequent in autoimmune diseases as compared to hematological malignancies: A French nationwide study

Guillaume Bayer, Marie‐Sara Agier, Bertrand Lioger et al. · European Journal of Internal Medicine · 2019 · 53 citations · Full text

, , +16

1–2 of 2